• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT Back to Search Results
Catalog Number 414967
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) reported the occurrence of a false susceptible fluconazole result for candida albicans in association with the vitek® 2 ast-ys07 test kit.Etest fluconazole provided a resistant result.Repeat testing obtained the same respective results.The customer reports a delay in reporting due to the additional testing performed.The patient was treated with a different antimycoticum.The customer sent the patient strain to a reference laboratory.The reference laboratory obtained results of resistant to fluconazole (test method unknown), confirming the vitek® 2 ast-ys07 result to be discrepant.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.Internal biomérieux investigation will be conducted.
 
Manufacturer Narrative
A biomerieux investigation was initiated due to a false susceptible fluconazole result on the ast-ys07 card for a candida albicans isolate, compared to etest® and reference lab results (resistant).The customer also observed the same issue on voriconazole.The reference method was performed to determine the intended results for fluconazole and voriconazole bmd (broth microdilution), compared with vitek® 2 (v6.01) and ast-ys07 cards.Category interpretations based on vitek® 2 breakpoints were: fluconazole: s/=64.Voriconazole: s/=4.Two different lots of ast- ys07 cards were tested: the customer lot 287394320 and a random lot 287389420.Test results obtained with bmd: - fluconazole reference mic >64mg/l resistant.-voriconazole reference mic>16 mg/l resistant.Results confirmed those obtained by the reference institute.On vitek® 2, the results obtained on both lots tested were flu mic <= 1mg/l s and vrc mic <=0.125mg/l s.The investigation duplicated the customer results.The investigation concluded the submitted isolate has an atypical biochemical profile.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-YS07 TEST KIT
Type of Device
VITEK® 2 AST-YS07 TEST KIT
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
hazelwood, MO 63042
3147317301
MDR Report Key5949551
MDR Text Key54694576
Report Number1950204-2016-00122
Device Sequence Number1
Product Code NGZ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K133817
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 01/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/14/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2017
Device Catalogue Number414967
Device Lot Number287394320
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/03/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/31/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-